Trial Profile
Clinical Characteristics of Rheumatoid Arthritis Patients Newly Prescribed Tofacitinib Citrate in the United States after Food and Drug Administration Approval
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 28 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.